跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PALIPERIDONA RATIOPHARM 25 MG SUSPENSION INYECTABLE DE LIBERACION PROLONGADA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
PALIPERIDONA RATIOPHARM 25 MG SUSPENSION INYECTABLE DE LIBERACION PROLONGADA EFG
Approved
STANDARD
PALIPERIDONA RATIOPHARM 25 MG SUSPENSION INYECTABLE DE LIBERACION PROLONGADA EFG
Ratiopharm Espana S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Dec 9, 2021
Approval ID
1c46ff90ab44c471
Company
Ratiopharm Espana S.A.
Type
Standard
Approval Details
Approval Id
1c46ff90ab44c471
Drug Cima Aemps Name
PALIPERIDONA RATIOPHARM 25 MG SUSPENSION INYECTABLE DE LIBERACION PROLONGADA EFG
Register Number
86248
Holder Company Name
Ratiopharm Espana S.A.
Marketing Company Name
Laboratorios Farmaceuticos Rovi S.A.
Marketing Company Detail Path
/organization/laboratorios-farmaceuticos-rovi-sa
Authorization Date
2021-12-09
Dosage Form
SUSPENSION INYECTABLE DE LIBERACION PROLONGADA
Dose
25 mg
Route Of Administration
VÍA INTRAMUSCULAR
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Ratiopharm Espana S.A.
Company Information
Pharmaceutical Company Name
LABORATORIOS FARMACEUTICOS ROVI SA
Country Name
Spain
City Name
madrid,madrid,country_es
Address
CALLE JULIAN CAMARILLO 35
Website
https://www.rovi.es/en/
Active Ingredients
PALIPERIDONA PALMITATO
39 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Dec 9, 2021
Approval ID
1c46ff90ab44c471
Type
Standard
Back to CIMA-AEMPS Approvals